GCC Ophthalmic Drugs Market: Anti-Inflammatory Drugs and Glaucoma Drugs Leading the Charge
The GCC Ophthalmic Drugs Market is experiencing significant and steady growth, with specific drug classes acting as primary catalysts. The market, valued at USD 1,122.12 Million in 2024, is projected to reach USD 2,201.84 Million by 2035, driven by the critical roles of these medications in managing prevalent and serious eye conditions. The Anti-Inflammatory...
0 Comments 0 Shares 2 Views 0 Reviews